These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12134264)

  • 1. Local nerve damage in leprosy does not lead to an impaired cellular immune response or decreased wound healing in the skin.
    Siddiqui MR; Moreira AL; Negesse Y; Taye GA; Hanekom WA; Haslett PA; Britton S; Kaplan G
    J Infect Dis; 2002 Jul; 186(2):260-5. PubMed ID: 12134264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of delayed hypersensitivity skin reactions to tuberculin by M. leprae antigens in patients with lepromatous and tuberculoid leprosy.
    Sengupta U; Sinha S; Ramu G; Lamb J; Ivanyi J
    Clin Exp Immunol; 1987 Apr; 68(1):58-64. PubMed ID: 3308210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD1a and factor XIIIa immunohistochemistry in leprosy: a possible role of dendritic cells in the pathogenesis of Mycobacterium leprae infection.
    Simões Quaresma JA; de Oliveira MF; Ribeiro Guimarães AC; de Brito EB; de Brito RB; Pagliari C; de Brito AC; Xavier MB; Seixas Duarte MI
    Am J Dermatopathol; 2009 Aug; 31(6):527-31. PubMed ID: 19590423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinical, immunological, and histological study of neuritic leprosy patients.
    Kaur G; Girdhar BK; Girdhar A; Malaviya GN; Mukherjee A; Sengupta U; Desikan KV
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):385-91. PubMed ID: 1890361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of Mycobacterium leprae soluble antigens to suppress delayed-type hypersensitivity reaction to tuberculin.
    Fine PE; Gruer PJ; Maine N; Ponnighaus JM; Rees RJ; Stanford JL
    Clin Exp Immunol; 1989 Aug; 77(2):226-9. PubMed ID: 2673590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microscopic findings of delayed reactions elicited by the skin test reagent Leprosin A derived from M. leprae.
    Samuel NM; Stanford JL; Desikan KV
    Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):395-403. PubMed ID: 3900246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nature and kinetics of a delayed immune response to purified protein derivative of tuberculin in the skin of lepromatous leprosy patients.
    Kaplan G; Laal S; Sheftel G; Nusrat A; Nath I; Mathur NK; Mishra RS; Cohn ZA
    J Exp Med; 1988 Nov; 168(5):1811-24. PubMed ID: 3053962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nerve damage following intraneural injection of Mycobacterium leprae into rabbits pre-sensitized to mycobacteria.
    Mshana RN; Humber DP; Harboe M; Belehu A
    Clin Exp Immunol; 1983 May; 52(2):441-8. PubMed ID: 6345041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of Schwann cells, T cells and Mycobacterium leprae in the immunopathogenesis of nerve damage in leprosy.
    Spierings E; De Boer T; Zulianello L; Ottenhoff TH
    Lepr Rev; 2000 Dec; 71 Suppl():S121-9. PubMed ID: 11201869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistological analysis of skin reaction to My1 derived from Mycobacterium leprae.
    Narayanan RB; Ramu G; Malaviya GN; Sinha S; Sengupta U
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):46-51. PubMed ID: 3519804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a cell-mediated reaction to the purified protein derivative of tuberculin in the disposal of Mycobacterium leprae from human skin.
    Kaplan G; Sheftel G; Job CK; Mathur NK; Nath I; Cohn ZA
    Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5210-4. PubMed ID: 2969108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Delayed cutaneous response to different antigens in household contacts of leprosy patients and controls].
    Bottasso O; Poli HO; Morini JC
    Med Cutan Ibero Lat Am; 1987; 15(6):504-10. PubMed ID: 3323710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
    Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
    Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune responsiveness to Mycobacterium leprae and other mycobacterial antigens throughout the clinical and histopathological spectrum of leprosy.
    Myrvang B; Godal T; Ridley DS; Fröland SS; Song YK
    Clin Exp Immunol; 1973 Aug; 14(4):541-53. PubMed ID: 4583777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic efficacy of cutaneous nerve biopsy in primary neuritic leprosy.
    Jacob M; Mathai R
    Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):56-60. PubMed ID: 3373086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Segmental necrotizing granulomatous neuritis of leprosy.
    Chandi SM; Chacko CJ; Fritschi EP; Job CK
    Int J Lepr Other Mycobact Dis; 1980 Mar; 48(1):41-7. PubMed ID: 6988346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
    Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
    Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of bovine cutaneous delayed-type hypersensitivity (DTH) to various test antigens and a mitogen using several adjuvants.
    Hernández A; Yager JA; Wilkie BN; Leslie KE; Mallard BA
    Vet Immunol Immunopathol; 2005 Mar; 104(1-2):45-58. PubMed ID: 15661330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA and leprosy in the pre and postgenomic eras.
    Geluk A; Ottenhoff TH
    Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thalidomide does not modify the ability of cells in leprosy patients to incorporate [3H]-thymidine when incubated with M. leprae antigens.
    Tadesse A; Taye E; Sandoval F; Shannon EJ
    Lepr Rev; 2003 Sep; 74(3):206-14. PubMed ID: 14577465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.